IP Library › Patent Application 13585325
Patent Application
App. No. 13/585,325

Devices and Methods for Tissue Engineering

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
13/585,325
Abstract

A resorbable tissue scaffold in a glass ceramic composition forms a rigid three-dimensional porous matrix having a bioactive composition. Porosity in the form of interconnected pore space is provided by the space between the glass-ceramic fiber forming the porous matrix. Strength of the porous matrix is provided by the interconnected and bonded fiber that fuses into the rigid three-dimensional matrix. The resorbable tissue scaffold supports tissue ingrowth when implanted as a device for the repair of damaged and/or diseased bone tissue.

Claims (18)

1 . A porous tissue scaffold comprising:

a porous rigid matrix having a glass-ceramic composition of a bioactive glass phase and a calcium silicate ceramic phase;

the glass-ceramic composition having interconnected pore space within the porous rigid matrix to provide porosity of about 20% to about 85%; and

the interconnected pore space having a pore size sufficient to promote tissue ingrowth when implanted in living tissue.

2 . The porous tissue scaffold according to claim 1 wherein the calcium silicate ceramic phase is wollastonite.

3 . The porous tissue scaffold according to claim 1 wherein the calcium silicate ceramic phase is greater than 50% of the glass-ceramic composition.

4 . The porous tissue scaffold according to claim 1 wherein the calcium silicate ceramic phase is greater than 40% of the glass-ceramic composition.

5 . The porous tissue scaffold according to claim 1 wherein the calcium silicate ceramic phase is greater than 20% of the glass-ceramic composition.

6 . The porous tissue scaffold according to claim 1 wherein the bioactive glass phase is a glass composition consisting essentially of silica, magnesium, phosphorus, sodium, and potassium.

7 . The porous tissue scaffold according to claim 1 wherein the bioactive glass phase contains essentially no calcium oxide.

8 . The porous tissue scaffold according to claim 1 further comprising a compressive strength of greater than 50 MPa.

9 . The porous tissue scaffold according to claim 8 wherein the pore size has an average value between about 40 μm and about 600 μm.

10 . The porous tissue scaffold according to claim 8 wherein the glass-ceramic composition is heat treated.

11 . A method of filling a defect in a bone comprising:

filling a space in the bone with a porous tissue scaffold comprising a porous rigid matrix having a glass-ceramic composition of a bioactive glass phase and a wollastonite ceramic phase; and

inserting the porous tissue scaffold into the defect in the bone.

12 . The method according to claim 11 wherein the bone is a vertebrae.

13 . The method according to claim 11 wherein the porous tissue scaffold is substantially wedge-shaped and the defect is an osteotomy.

Assignments (4)
SECURITY INTEREST Recorded Dec 3, 2021
From: NOVUM MEDICAL, INC.
To: DSM VENTURING B.V.
Reel/Frame 058283/0638 →
SECURITY INTEREST Recorded Dec 8, 2020
From: BIO2 TECHNOLOGIES, INC.
To: DSM VENTURING B.V.
Reel/Frame 054577/0284 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 15, 2013
From: LEWIS, CASEY S.
To: BIO2 TECHNOLOGIES, INC.
Reel/Frame 029632/0679 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 22, 2012
From: LIU, JAMES J.
To: BIO2 TECHNOLOGIES, INC.
Reel/Frame 028829/0506 →